Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Azacitidine and the beginnings of therapeutic epigenetic modulation
Expert Opinion in Pharmacotherapy, 07/24/08
O'Dwyer K et al. - The use of azacitidine has changed the approach to the treatment of MDS and has resulted in improved outcomes for patients.
Related Articles
The role of azacitidine in the management of myelodysplastic syndromes (MDS)
Cancer Management and Research, 10/13/09
Relevance Score: 87%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Efficacy of escalated imatinib combined with cytarabine in newly diagnosed patients with chronic myeloid leukemia
Haematologica, 12/18/09
Nilotinib As Front-Line Treatment for Patients With Chronic Myeloid Leukemia in Early Chronic Phase
Journal of Clinical Oncology, 12/18/09
How do providers assess antihypertensive medication adherence in medical encounters?
Journal of General Internal Medicine, 12/18/09
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Should routine screening by mammography be replaced by a more selective service of risk assessment/risk management?
Women's Health, 12/18/09
Pain in patients with lung cancer: Pathophysiology and treatment
Lung Cancer, 12/18/09
Initial testing of topotecan by the pediatric preclinical testing program
Pediatric Blood & Cancer, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


